Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
7.59
-0.31 (-3.92%)
At close: Feb 21, 2025, 4:00 PM
7.85
+0.26 (3.43%)
After-hours: Feb 21, 2025, 6:05 PM EST
Contineum Therapeutics Employees
Contineum Therapeutics had 31 employees as of December 31, 2023.
Employees
31
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$931,839
Market Cap
195.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
CTNM News
- 6 weeks ago - Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) - Business Wire
- 2 months ago - Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791 - Business Wire
- 3 months ago - Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference - Business Wire
- 3 months ago - Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain - Business Wire
- 3 months ago - Contineum Therapeutics to Attend Upcoming Investor Conferences - Business Wire
- 3 months ago - Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
- 6 months ago - Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences - Business Wire
- 6 months ago - Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Business Wire